Viewing Study NCT00839410



Ignite Creation Date: 2024-05-05 @ 9:11 PM
Last Modification Date: 2024-10-26 @ 10:01 AM
Study NCT ID: NCT00839410
Status: COMPLETED
Last Update Posted: 2019-10-04
First Post: 2009-02-06

Brief Title: Multicentric Cohort of Melanoma Patients in Ile de France Area
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization: Assistance Publique - Hôpitaux de Paris

Study Overview

Official Title: Multicentric Cohort of Melanoma Patients in Ile de France Area
Status: COMPLETED
Status Verified Date: 2019-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Melan-Cohort
Brief Summary: This is a multicentric prospective cohort of all stage melanoma patients from AP-HP the largest consortium of University hospitals over Europe 7 investigation sites 7 dermatological services of AP-HP in Ile de France region are involved 1300 patients will be enrolled and be followed during 10 years
Detailed Description: Melan-Cohort should constitute the first multicentric cohort with various objectives prognostic therapeutic cognitive and medico-economical studies on melanoma Patients will be recruited in all of the dermatology departments of APHP dermatology departments from AMBROISE PARE Saint-Louis BICHAT-Claude BernardHenri-Mondor Cochin-Tarnier and Tenon hospitals For all included patients a standard file is filled comprising all anatomy-clinical useful data and epidemiologic ones including sun exposures Blood is harvested to collect DNA RNA serum plasma at inclusion and at regular intervals and in case of progressive disease Procedures for sentinel lymph node biopsies have been homogenized An informed consent is obtained for each patient included in the cohort A steering committee meets on a regular basis and genetics or pathology subgroups have been constituted An electronic CRF is available using the Intranet of APHP hospitals Specimens are stored using high quality standards

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None